APA (7th ed.) Citation

MJ, F., JH, B., AM, K., HK, S., S, P., AK, B., . . . DB, M. (2024). CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: A dose-finding phase 1 study. Lancet (London, England), 404(10450), 353. https://doi.org/10.1016/S0140-6736(24)00746-3

Chicago Style (17th ed.) Citation

MJ, Frank, et al. "CD22-directed CAR T-cell Therapy for Large B-cell Lymphomas Progressing After CD19-directed CAR T-cell Therapy: A Dose-finding Phase 1 Study." Lancet (London, England) 404, no. 10450 (2024): 353. https://doi.org/10.1016/S0140-6736(24)00746-3.

MLA (9th ed.) Citation

MJ, Frank, et al. "CD22-directed CAR T-cell Therapy for Large B-cell Lymphomas Progressing After CD19-directed CAR T-cell Therapy: A Dose-finding Phase 1 Study." Lancet (London, England), vol. 404, no. 10450, 2024, p. 353, https://doi.org/10.1016/S0140-6736(24)00746-3.